CME Group Inc (NASDAQ:CME) has received an average rating of “Hold” from the seventeen analysts that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $200.00.
Several analysts recently commented on CME shares. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Thursday, September 12th. Barclays lifted their target price on shares of CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a report on Thursday, May 23rd. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price for the company. in a report on Monday, May 27th. UBS Group lifted their target price on shares of CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a report on Thursday, September 5th. Finally, Wells Fargo & Co lifted their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd.
In other CME Group news, Director Daniel R. Glickman sold 500 shares of CME Group stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $216.01, for a total value of $108,005.00. Following the completion of the sale, the director now owns 14,593 shares in the company, valued at approximately $3,152,233.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. Insiders sold a total of 59,626 shares of company stock valued at $12,255,934 in the last quarter. Corporate insiders own 1.20% of the company’s stock.
Shares of CME traded down $0.85 during midday trading on Friday, reaching $211.10. The stock had a trading volume of 77,942 shares, compared to its average volume of 1,260,292. The firm has a market cap of $75.78 billion, a PE ratio of 30.95, a P/E/G ratio of 4.59 and a beta of 0.19. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The firm has a 50 day simple moving average of $212.30 and a 200-day simple moving average of $192.06. CME Group has a one year low of $161.05 and a one year high of $224.91.
CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.74 EPS. As a group, research analysts forecast that CME Group will post 6.73 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: What is a Derivative?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.